Collectively, aberrant lipogenesis and changes in lipid and glucose metabolism are key features of metabolic reprogramming, which may induce aberrant activation of KRAS signaling and a sustained pro-inflammatory environment, leading to cancer initiation. The gene discussed is KRAS; the disease is cancer.